1. Home
  2. MYNZ vs SMTK Comparison

MYNZ vs SMTK Comparison

Compare MYNZ & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • SMTK
  • Stock Information
  • Founded
  • MYNZ 2021
  • SMTK 2009
  • Country
  • MYNZ Germany
  • SMTK United Kingdom
  • Employees
  • MYNZ N/A
  • SMTK N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • SMTK
  • Sector
  • MYNZ Health Care
  • SMTK
  • Exchange
  • MYNZ Nasdaq
  • SMTK NYSE
  • Market Cap
  • MYNZ 5.5M
  • SMTK 6.1M
  • IPO Year
  • MYNZ 2021
  • SMTK N/A
  • Fundamental
  • Price
  • MYNZ $1.37
  • SMTK $0.93
  • Analyst Decision
  • MYNZ Buy
  • SMTK
  • Analyst Count
  • MYNZ 2
  • SMTK 0
  • Target Price
  • MYNZ $14.00
  • SMTK N/A
  • AVG Volume (30 Days)
  • MYNZ 118.7K
  • SMTK 150.8K
  • Earning Date
  • MYNZ 07-07-2025
  • SMTK 08-11-2025
  • Dividend Yield
  • MYNZ N/A
  • SMTK N/A
  • EPS Growth
  • MYNZ N/A
  • SMTK N/A
  • EPS
  • MYNZ N/A
  • SMTK N/A
  • Revenue
  • MYNZ $893,991.00
  • SMTK $105,000.00
  • Revenue This Year
  • MYNZ $26.06
  • SMTK N/A
  • Revenue Next Year
  • MYNZ $4.97
  • SMTK N/A
  • P/E Ratio
  • MYNZ N/A
  • SMTK N/A
  • Revenue Growth
  • MYNZ N/A
  • SMTK 854.54
  • 52 Week Low
  • MYNZ $1.34
  • SMTK $0.78
  • 52 Week High
  • MYNZ $22.40
  • SMTK $7.80
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 23.25
  • SMTK N/A
  • Support Level
  • MYNZ $1.34
  • SMTK N/A
  • Resistance Level
  • MYNZ $1.48
  • SMTK N/A
  • Average True Range (ATR)
  • MYNZ 0.13
  • SMTK 0.00
  • MACD
  • MYNZ -0.01
  • SMTK 0.00
  • Stochastic Oscillator
  • MYNZ 3.72
  • SMTK 0.00

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About SMTK SMARTKEM INC

SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in several applications, including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.

Share on Social Networks: